MedPath
HSA Approval

EMELIV TABLET 10 mg

SIN03435P

EMELIV TABLET 10 mg

EMELIV TABLET 10 mg

June 17, 1989

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A03FA01

metoclopramide

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

METOCLOPRAMIDE HCl EQV ANHYDROUS METOCLOPRAMIDE HCl

10 mg

Metoclopramide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EMELIV TABLET 10 mg - HSA Approval | MedPath